Bleeding Academic Research Consortium Type 3 or 5 was associated with an increased mortality rate at 2 years ( adjusted HR : 7.72 ; 95 % CI : 4.75-12 .54 ) similar to that provided by TIMI ( HR : 7.64 , 95 % CI : 4.53-12 .87 ) or GUSTO ( HR : 7.36 , 95 % CI : 4.38-12 .34 ) criteria .